Literature DB >> 21038

Clinical usefulness of alkaline phosphatase isoenzyme determinations.

L Gorman, B E Statland.   

Abstract

1. We report on the clinical usefulness of alkaline phosphatase isoenzyme determinations using a combined chemical inhibition method on 731 patient serum specimens exhibiting elevated (greater than 350 U/L) alkaline phosphatase (AP) activity. 2. The relative percentages of the organ-specific alkaline phosphatase activities were computed on the basis of three independent assays: total activity, activity in the presence of 10 mMl-phenylalanine, and activity in the presence of 3.1 M urea. 3. Gamma-glutamyl transferase (GGT) activity assays were also performed on the same specimens. Using an upper reference limit of 30 U/L for GGT and comparing the GGT results with the percent liver AP, we found that the GGT results were 91% sensitive and 60% specific. 4. We conclude that AP isoenzyme determinations are very useful in identifying the organ source(s) responsible for elevated AP values. 5. The reference ranges for several age groups in relation to the adult population and their significance are presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21038     DOI: 10.1016/s0009-9120(77)92552-8

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

2.  The accuracy of alkaline phosphatase isoenzyme determination.

Authors:  G C Lamb; G Roush
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

3.  Risk factors for pulmonary complications after hepatic resection: role of intraoperative hemodynamic instability and hepatic ischemia.

Authors:  Victoria Lepere; Antoine Vanier; Yann Loncar; Louis Lemoine; Jean Christophe Vaillant; Antoine Monsel; Eric Savier; Pierre Coriat; Daniel Eyraud
Journal:  BMC Anesthesiol       Date:  2017-06-20       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.